Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $3,000 | 1 | 45.9% |
| Food and Beverage | $2,235 | 101 | 34.2% |
| Travel and Lodging | $633.70 | 4 | 9.7% |
| Consulting Fee | $550.00 | 1 | 8.4% |
| Education | $109.73 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,020 | 2 | $0 (2022) |
| Boston Scientific Corporation | $813.70 | 7 | $0 (2019) |
| Covidien LP | $550.00 | 1 | $0 (2020) |
| AbbVie Inc. | $536.50 | 24 | $0 (2020) |
| Astellas Pharma US Inc | $419.38 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $327.68 | 16 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $117.45 | 9 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $109.73 | 5 | $0 (2019) |
| Amgen Inc. | $88.20 | 1 | $0 (2018) |
| Roche Diagnostics Corporation | $65.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.61 | 7 | Sumitomo Pharma America, Inc. ($52.97) |
| 2023 | $130.86 | 6 | Astellas Pharma US Inc ($97.30) |
| 2022 | $3,115 | 7 | Intuitive Surgical, Inc. ($3,000) |
| 2021 | $134.06 | 7 | TherapeuticsMD, Inc. ($24.93) |
| 2020 | $807.86 | 10 | Covidien LP ($550.00) |
| 2019 | $476.46 | 26 | AbbVie, Inc. ($169.25) |
| 2018 | $1,371 | 33 | BOSTON SCIENTIFIC CORPORATION ($778.82) |
| 2017 | $345.92 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($69.99) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Endocrinology | ||||||
| 09/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Womens Health | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: UROLOGY | ||||||
| 08/02/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Endocrinology | ||||||
| 04/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: UROLOGY | ||||||
| 04/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Womens Health | ||||||
| 02/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Biological | ||||||
| 11/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Biological | ||||||
| 06/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Biological | ||||||
| 06/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Biological | ||||||
| 04/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Womens Health | ||||||
| 03/29/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Urology | ||||||
| 01/14/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ETONOGESTREL | ||||||
| 10/21/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: ETONOGESTREL | ||||||
| 09/27/2022 | Medtronic, Inc. | V-LOC 180 (Device) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Wound Closure | ||||||
| 09/16/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2022 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Debt forgiveness | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 07/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Womens Health | ||||||
| 01/22/2022 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $38.16 | General |
| Category: Urogynaecology | ||||||
| 11/12/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: Urology | ||||||
| 09/07/2021 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/06/2021 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/03/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CONTRACEPTIVES | ||||||
| 07/09/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 134 | 166 | $26,339 | $9,230 |
| 2022 | 4 | 129 | 160 | $25,365 | $9,219 |
| 2021 | 4 | 124 | 159 | $26,757 | $10,591 |
| 2020 | 4 | 121 | 163 | $26,232 | $9,671 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 70 | $12,861 | $4,255 | 33.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 48 | 48 | $3,905 | $1,824 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,830 | $1,727 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $2,870 | $768.75 | 26.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,873 | $655.65 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 73 | $13,943 | $4,576 | 32.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 61 | 61 | $4,880 | $2,373 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $3,252 | $1,209 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,290 | $1,061 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 78 | $14,178 | $5,333 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 23 | $5,945 | $2,230 | 37.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 44 | 44 | $3,520 | $1,804 | 51.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,114 | $1,224 | 39.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 83 | $13,114 | $4,402 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 27 | $6,180 | $2,299 | 37.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 18 | 18 | $4,068 | $1,505 | 37.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 35 | 35 | $2,870 | $1,465 | 51.1% |
About Dr. Steven Schneider, MD
Dr. Steven Schneider, MD is a Obstetrics & Gynecology healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063421659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Schneider, MD has received a total of $6,529 in payments from pharmaceutical and medical device companies, with $147.61 received in 2024. These payments were reported across 112 transactions from 25 companies. The most common payment nature is "Debt forgiveness" ($3,000).
As a Medicare-enrolled provider, Schneider has provided services to 508 Medicare beneficiaries, totaling 648 services with total Medicare billing of $38,712. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Wakefield, RI
- Active Since 08/05/2006
- Last Updated 11/12/2015
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1063421659
Products in Payments
- DAVINCI XI (Device) $3,000
- UPHOLD LITE (Device) $778.82
- Orilissa (Drug) $303.77
- MYRBETRIQ (Drug) $254.60
- Kyleena (Drug) $229.60
- ORILISSA (Drug) $150.37
- Veozah (Drug) $98.94
- Mirena (Drug) $98.08
- Prolia (Biological) $88.20
- NEXPLANON (Drug) $88.19
- INTRAROSA (Drug) $85.91
- Lupron (Drug) $82.36
- GEMTESA (Drug) $77.32
- RS Harmony Test Related Products (Device) $65.53
- XTANDI (Drug) $63.56
- SURGICEL Family of Absorbable Hemostats (Device) $53.54
- NUVARING (Drug) $52.10
- Myrbetriq (Drug) $43.81
- Desara (Device) $38.16
- Paragard T 380A (Drug) $37.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Wakefield
Dr. Mary Christina Simpson, M.d, M.D
Obstetrics & Gynecology — Payments: $50,223
Lisa Rameaka, M.d, M.D
Obstetrics & Gynecology — Payments: $7,392
Dr. Daniel Witkowski, Md, MD
Obstetrics & Gynecology — Payments: $2,338
Megin Dalton, M.d, M.D
Obstetrics & Gynecology — Payments: $2,247
Andrew Neuhauser, M.d, M.D
Obstetrics & Gynecology — Payments: $901.92
Jeffrey Joseph, M.d, M.D
Obstetrics & Gynecology — Payments: $624.16